V th, thng xuyn b sung v duy tr nng L-glutathione mc n nh gip tng cng sc khng v bo v c th trc cc yu t gy bnh
New England Journal of Medicine 2023 03 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial Rosenstock J, Frias J, Jastreboff AM, et al
If symptoms do occur, dose reduction often helps
These findings only continue to highlight the wide-ranging safety concerns associated with the use of the drug
Liraglutide and exendin-4 are initially antidiabetic drugs but can affect tumorigenesis, suggesting GLP-1R agonists as a potential treatment for different cancers as found in vivo (Table 2)
Excess body weight puts more pressure on the veins in the lower rectum and anus